Results 41 to 50 of about 136,887 (323)

Myocarditis: Pathologist's perspective

Journal of the Practice of Cardiovascular Sciences, 2015
Myocarditis is a challenging diagnosis for both clinician and pathologist due to the extreme diversity of clinical presentation and low sensitivity of detection of myocarditis in the endomyocardial samples. The exact incidence of myocarditis is still not
Sudheer Arava, Ruma Ray, Sandeep Seth, Firdaus Ali, Parul Jain   +4 more
doaj   +1 more source

Myocarditis and inflammatory cardiomyopathy: current evidence and future directions

Nature Reviews Cardiology, 2020
Inflammatory cardiomyopathy, characterized by inflammatory cell infiltration into the myocardium and a high risk of deteriorating cardiac function, has a heterogeneous aetiology.
C. Tschöpe, E. Ammirati, B. Bozkurt, A. Caforio, L. Cooper, S. Felix, J. Hare, Bettina Heidecker, S. Heymans, N. Hübner, S. Kelle, K. Klingel, H. Maatz, A. Parwani, F. Spillmann, R. Starling, H. Tsutsui, P. Seferovic, S. Van Linthout   +18 more
semanticscholar   +1 more source

Sex and gender differences in myocarditis and dilated cardiomyopathy: An update

Frontiers in Cardiovascular Medicine, 2023
In the past decade there has been a growing interest in understanding sex and gender differences in myocarditis and dilated cardiomyopathy (DCM), and the purpose of this review is to provide an update on this topic including epidemiology, pathogenesis ...
D. Fairweather, Danielle J Beetler, Nicolas Musigk, Bettina Heidecker, M. Lyle, L. Cooper, K. A. Bruno   +6 more
semanticscholar   +1 more source

Parametric Mapping Cardiac Magnetic Resonance Imaging for the Diagnosis of Myocarditis in Children in the Era of COVID-19 and MIS-C

Children, 2022
Myocarditis comprises many clinical presentations ranging from asymptomatic to sudden cardiac death. The history, physical examination, cardiac biomarkers, inflammatory markers, and electrocardiogram are usually helpful in the initial assessment of ...
Bibhuti B. Das, Jyothsna Akam-Venkata, Mubeena Abdulkarim, Tarique Hussain   +3 more
doaj   +1 more source

Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis

Circulation, 2023
BACKGROUND: Immune checkpoint inhibitors (ICIs) are approved for multiple cancers but can result in ICI-associated myocarditis, an infrequent but life-threatening condition.
L. Lehmann, M. Heckmann, Guillaume Bailly, D. Finke, Adrien Procureur, J. Power, Frederic Stein, M. Bretagne, S. Ederhy, C. Fenioux, Omar Hamwy, E. Funck-Brentano, E. Romano, L. Pieroni, Jan Münster, Y. Allenbach, C. Anquetil, S. Leonard-Louis, Nicolas L. Palaskas, S. Hayek, H. Katus, E. Giannitsis, N. Frey, Z. Kaya, J. Moslehi, Edi Prifti, J. Salem   +26 more
semanticscholar   +1 more source

Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection

European Heart Journal, 2020
Simone Sala , Giovanni Peretto *, Mario Gramegna , Anna Palmisano , Andrea Villatore , Davide Vignale , Francesco De Cobelli, Moreno Tresoldi , Alberto Maria Cappelletti, Cristina Basso, Cosmo Godino, and Antonio Esposito 2,4† Department of Cardiac ...
S. Sala, G. Peretto, M. Gramegna, A. Palmisano, A. Villatore, D. Vignale, F. de Cobelli, M. Tresoldi, A. Cappelletti, C. Basso, C. Godino, A. Esposito   +11 more
semanticscholar   +1 more source

Recognition and Initial Management of Fulminant Myocarditis

Circulation, 2020
Fulminant myocarditis (FM) is an uncommon syndrome characterized by sudden and severe diffuse cardiac inflammation often leading to death resulting from cardiogenic shock, ventricular arrhythmias, or multiorgan system failure. Historically, FM was almost
R. Kociol, L. Cooper, J. Fang, J. Moslehi, P. Pang, Marwa Sabe, R. Shah, D. Sims, G. Thiene, O. Vardeny   +9 more
semanticscholar   +1 more source

Differentiation between mild and severe myocarditis using multiparametric cardiac magnetic resonance

Radiology Case Reports, 2023
The pathophysiology of myocarditis is associated with mild inflammation and may progress silently, or in severe cases such as fulminant myocarditis, may lead to sudden hemodynamic compromise.
Hideo Arai, RT, Masateru Kawakubo, PhD, Kenichi Sanui, RT, Hiroshi Nishimura, MD, PhD, Toshiaki Kadokami, MD, PhD   +4 more
doaj   +1 more source

First case of COVID-19 complicated with fulminant myocarditis: a case report and insights

Infection, 2020
Background Coronavirus disease 2019 (COVID-19) has been demonstrated to be the cause of pneumonia. Nevertheless, it has not been reported as the cause of acute myocarditis or fulminant myocarditis.
J. Zeng, Yingxia Liu, Jing Yuan, Fu-xiang Wang, Weibo Wu, Jin-xiu Li, Lifei Wang, Hong-yu Gao, Yao Wang, Changfeng Dong, Yi-Jun Li, Xiaohong Xie, C. Feng, Lei Liu   +13 more
semanticscholar   +1 more source

SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents

JAMA cardiology, 2022
Key Points Question Is SARS-CoV-2 messenger RNA (mRNA) vaccination associated with risk of myocarditis? Findings In a cohort study of 23.1 million residents across 4 Nordic countries, risk of myocarditis after the first and second doses of SARS-CoV-2 ...
Ø. Karlstad, P. Hovi, A. Husby, T. Härkänen, R. Selmer, Nicklas Pihlström, J. V. Hansen, H. Nohynek, N. Gunnes, A. Sundström, J. Wohlfahrt, T. Nieminen, Maria Grünewald, H. Gulseth, A. Hviid, R. Ljung   +15 more
semanticscholar   +1 more source